EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MIL-101 (Cr) metal–organic frameworks for systemic delivery of rifampicin antibiotic to lungs

Aziz Mirkasymov iD, Danila Pokhorukov iD, Iaroslav Belyaev iD, Polina Kotelnikova iD, Olga Griaznova iD, Daria Trushina iD, Ivan Zelepukin iD, Sergey Deyev iD

Biomedical Materials · 2026

DOI: 10.1088/1748-605x/ae32d9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Materials, 2026. Verfasst von Aziz Mirkasymov und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia. Hauptthemen laut MEDLINE: Rifampin, Lung, Metal-Organic Frameworks, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory pulmonary infections are a serious threat to human health. Their therapy is primarily based on the use of antibiotics. However, non-specific accumulation and low concentration in the target tissue reduce therapeutic effectiveness, cause side effects, and promote the development of antibiotic resistance. In this study, metal–organic frameworks (MOFs) with MIL-101 (Cr) structure were used for delivery of rifampicin to the lungs. The nanoparticles (NPs) showed high antibiotic loading by mass, namely (127 ± 8)% for MIL-101 (Cr) and (82 ± 7)% for amino-modified NH 2 -MIL-101 (Cr). The kinetics of drug release had rapid and prolonged phases with up to 40% of the loaded drug released in 7 h. It induces a significant inhibition of bacterial viability at a concentration of NPs as low as 1 mg l −1 . After intravenous administration, the particles showed high tropism for lung accumulation reaching concentration of almost 300%/g of tissue, more than 10 times higher than concentrations in other tissues. This study demonstrates the effectiveness of using MIL-101 (Cr) MOFs for pulmonary drug delivery and holds significant promise for developing antibacterial therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RifampinLungMetal-Organic FrameworksAnti-Bacterial AgentsDrug Delivery SystemsAnimalsNanoparticlesHumansTissue DistributionMiceDrug Liberation

Stichwörter der Autor:innen

antibacterial therapymetal–organic frameworkspulmonary deliveryrifampicin

Substanzen

RifampinMetal-Organic FrameworksAnti-Bacterial AgentsMIL-101

Autor:innen und Institutionen

  • Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
  • National Research Nuclear University 'MEPhI', Moscow, Russia.
  • A.V. Shubnikov Institute of Crystallography of the Kurchatov Complex Crystallography and Photonics of the NRC 'Kurchatov Institute', Moscow, Russia.
  • Department of Immunology Genetics and Pathology, Uppsala University, Uppsala, Sweden.

ORCID-Profile: Aziz Mirkasymov, Danila Pokhorukov, Iaroslav Belyaev, Polina Kotelnikova, Olga Griaznova, Daria Trushina, Ivan Zelepukin, Sergey Deyev

Förderung

  • Russian Science Foundation

Zitieren

APA

Mirkasymov, A., Pokhorukov, D., Belyaev, I., Kotelnikova, P., Griaznova, O., Trushina, D., Zelepukin, I., & Deyev, S. (2026). MIL-101 (Cr) metal–organic frameworks for systemic delivery of rifampicin antibiotic to lungs. Biomedical Materials. https://doi.org/10.1088/1748-605x/ae32d9

Vancouver

Mirkasymov A, Pokhorukov D, Belyaev I, Kotelnikova P, Griaznova O, Trushina D, et al. MIL-101 (Cr) metal–organic frameworks for systemic delivery of rifampicin antibiotic to lungs. Biomedical Materials. 2026. doi:10.1088/1748-605x/ae32d9

BibTeX
@article{Mirkasymov2026,
  author = {Mirkasymov, Aziz and Pokhorukov, Danila and Belyaev, Iaroslav and Kotelnikova, Polina and Griaznova, Olga and Trushina, Daria and Zelepukin, Ivan and Deyev, Sergey},
  title = {MIL-101 (Cr) metal–organic frameworks for systemic delivery of rifampicin antibiotic to lungs},
  journal = {Biomedical Materials},
  year = {2026},
  doi = {10.1088/1748-605x/ae32d9}
}
Kostenlos starten →